文献速递流行病学与生物统计临床试验与 GCP

动态路径分析在具有时间至事件终点的临床试验中探索治疗效应中介过程

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time-to-event endpoints.
PubMed 文献 · Stat Med · 2024-08-07

针对纵向生物标志物预后价值与治疗获益不转化至生存获益的矛盾,本文介绍动态路径分析框架,可将总治疗效应分解为直接效应与通过纵向中介变量的间接效应,并描述效应随时间演变,用模拟与真实肿瘤数据展示其应用于生存中介分析。

要点

  • 动态路径分析可分解总治疗效应为直接效应和经纵向中介的间接效应。
  • 该方法能描述直接与间接效应随时间的变化,有助于机制理解。
  • 模拟与肿瘤真实数据分析展示了该方法在生存中介分析中的应用。

核心结论

  • 动态路径分析为具有时间至事件终点的临床试验提供了一种理论严谨的生存中介分析方法,可分解总治疗效应并刻画其随时间演变。

研究设计与样本

  • 方法学文章,介绍动态路径分析框架,并用模拟数据和肿瘤真实数据展示其在生存中介分析中的应用。

主要发现

  • 动态路径分析可将总治疗效应分解为直接治疗效应和通过精心构建的中介路径产生的间接治疗效应。
  • 该方法可描述直接效应与间接效应如何随时间演变,从而增进对潜在过程机制的理解。

临床怎么用

  • 作者提出动态路径分析可推广至以时间至事件为主要临床终点的广泛药物开发应用场景。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Why does a beneficial treatment effect on a longitudinal biomarker not translate into overall treatment benefit on survival, when the biomarker is in fact a prognostic factor of survival? In a recent exploratory data analysis in oncology, we were faced with this seemingly paradoxical result. To address this problem, we applied a theoretically principled methodology called dynamic path analysis, which allows us to perform mediation analysis with a longitudinal mediator and survival outcome. The aim of the analysis is to decompose the total treatment effect into a direct treatment effect and an indirect treatment effect mediated through a carefully constructed mediation path. The dynamic nature of the underlying methodology enables us to describe how these effects evolve over time, which can add to the mechanistic understanding of the underlying processes. In this paper, we present a detailed description of the dynamic path analysis framework and illustrate its application to survival mediation analysis using simulated and real data. The use case analysis provides clarity on the specific exploratory question of interest while the methodology generalizes to a wide range of applications in drug development where time-to-event is the primary clinical outcome of interest.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Kormaksson M, Lange MR, Demanse D, et al. Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time-to-event endpoints. Stat Med. 2024. PMID: 39109988. doi:10.1002/sim.10191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。